Imexpharm Corp operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Imexpharm Corp with three other companies in this sector in VIETNAM : DOMESCO Medical Import Export Joint Stock Corp (2019 sales of 1.47 trillion Vietnamese Dong [US$63.29 million] ), Medipharco Pharmaceutical JSC (1.13 trillion Vietnamese Dong [US$48.67 million] ), and Mekophar Chemical Pharma JSC (1.22 trillion Vietnamese Dong [US$52.46 million] ).

Sales Analysis. During the year ended December of 2019, sales at Imexpharm Corp were 1.40 trillion Vietnamese Dong (US$60.45 million). This is an increase of 18.4% versus 2018, when the company's sales were 1.18 trillion Vietnamese Dong . This was the fifth consecutive year of sales increases at Imexpharm Corp (and since 2014, sales have increased a total of 56%).